This study is looking at how a pregnant person's body handles caffeine citrate and how much of it reaches the baby. We want to understand how caffeine moves through the body during pregnancy. Each pregnant participant will receive a single dose of 100 mg of caffeine citrate before delivery. Blood samples will be taken from the pregnant mother, the placenta, and the newborn to measure caffeine levels. This information will help us create a computer model of how caffeine is processed during pregnancy. You may be able to join if you are a pregnant woman, 18 years or older, with a risk of preterm delivery between 23 and 31 weeks and 6 days of pregnancy, and are staying in the hospital until delivery. The study is currently unclear on its recruitment status.

Study design

This is an interventional study planning to enroll 30 pregnant women. Each participant will receive a single dose of caffeine citrate.

What's involved

You would receive a single dose of caffeine citrate. Blood samples would be taken from you, the placenta, and your newborn.

Compensation

Not stated in the trial record.

Follow-up

Caffeine levels will be measured at 3 hours after administration, which is the primary endpoint time frame.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.